Homo sapiens
Sequencing of the XPO1 resistance hotspot after treatment with selinexor
isolate
33
age
36 years
biomaterial_provider
ATCC - CCL-240
sex
female
tissue
Bone marrow cells (myeloblast)
cell_line
HL-60
cell_subtype
Neutrophilic promyelocyte
cell_type
suspesion
disease
Acute promyelocytic leukemia
target_amplicon
XPO1 exon15 - codon Cys528
treatment
1000 nM selinexor
BioSampleModel
Human